Alois Alzheimer and vascular brain disease: Arteriosclerotic atrophy of the brain. [PDF]
, 2015 Alois Alzheimer is best known for his description of neurofibrillary changes in brain neurons of a demented patient, identifying a novel disease, soon named after him by Kraepelin.
Engelhardt, Eliasz, Grinberg, Lea T
core +2 more sources
Therapeutic effects of dental pulp stem cells on vascular dementia in rat models
Neural Regeneration Research, 2021 Dental pulp stem cells are a type of adult stem cells with strong proliferative ability and multi-differentiation potential. There are no studies on treatment of vascular dementia with dental pulp stem cells.
Xue-Mei Zhang +11 more
doaj +1 more source
An evidence-based algorithm for the utility of FDG-PET for diagnosing Alzheimer's disease according to presence of medial temporal lobe atrophy [PDF]
, 2015 BackgroundImaging biomarkers for Alzheimer's disease include medial temporal lobe atrophy (MTLA) depicted on computed tomography (CT) or magnetic resonance imaging (MRI) and patterns of reduced metabolism on fluorodeoxyglucose positron emission ...
Cam Donaldson +13 more
core +1 more source
Identifying preclinical vascular dementia in symptomatic small vessel disease using MRI
NeuroImage: Clinical, 2018 Sporadic cerebral small vessel disease is an important cause of vascular dementia, a syndrome of cognitive impairment together with vascular brain damage.
Christian Lambert +8 more
doaj +1 more source
Frontiers in Aging Neuroscience, 2022 Backgroud: Vascular dementia is the second most common cause of dementia after Alzheimer’s disease, accounting for an estimated 15% of cases. Recently, Epimedium has attracted great attention for its potential neuroprotective benefit. However, the direct
Chenchen Xie +4 more
doaj +1 more source
Isolated Subtle Neurological Abnormalities in Mild Cognitive Impairment Types [PDF]
, 2020 Background: Isolated, subtle neurological abnormalities (ISNA) are commonly seen in aging and have been related to cerebral small vessel disease (SVD) and subcortical atrophy in neurologically and cognitively healthy aging subjects.
Azzarello, Delia +7 more
core +1 more source
Cognitive and mood assessment tools for use in stroke [PDF]
, 2018 No abstract ...
Elliott, Emma +2 more
core +1 more source
Long-term follow-up of cognitive function and activities of daily living in older people: a feasibility study in the PROSPER cohort [PDF]
, 2011 <p>Background: The Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) considered the benefits of pravastatin therapy and provided insights into cognitive decline/disability in older people but follow-up was short.</p> <p ...
Kerr, G.D., Robertson, M., Stott, D.J.
core +1 more source
Chonnam Medical Journal, 2011 Cerebrovascular disease is the second leading cause of cognitive impairment in the elderly, either alone or in combination with Alzheimer's disease (AD). Vascular dementia (VaD) is heterogeneous in terms of both clinical phenotype and pathogenetic mechanisms.
openaire +2 more sources
Prevalence of dementia subtypes in a developing country: a clinicopathological study
Clinics, 2013 OBJECTIVES: To assess the distribution of dementia subtypes in Brazil using a population-based clinicopathological study. METHOD: Brains from deceased individuals aged ≥50 years old were collected after the next of kin signed an informed consent form ...
Lea T. Grinberg +17 more
doaj +1 more source